57 related articles for article (PubMed ID: 7812948)
1. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
Cairns P; Tokino K; Eby Y; Sidransky D
Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
[TBL] [Abstract][Full Text] [Related]
2. Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma.
Kinoshita H; Yamada H; Ogawa O; Kakehi Y; Osaka M; Nakamura E; Mishina M; Habuchi T; Takahashi R; Sugiyama T
Jpn J Cancer Res; 1995 Sep; 86(9):795-9. PubMed ID: 7591954
[TBL] [Abstract][Full Text] [Related]
3. The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities.
Elias R; Zhang Q; Brugarolas J
Cancer J; 2020; 26(5):390-398. PubMed ID: 32947307
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.
El-Mokadem I; Lim A; Kidd T; Garret K; Pratt N; Batty D; Fleming S; Nabi G
BMC Cancer; 2016 Jul; 16():546. PubMed ID: 27465101
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.
El-Mokadem I; Fitzpatrick J; Bondad J; Rauchhaus P; Cunningham J; Pratt N; Fleming S; Nabi G
Br J Cancer; 2014 Sep; 111(7):1381-90. PubMed ID: 25137021
[TBL] [Abstract][Full Text] [Related]
6. Significance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies.
El-Mokadem I; Fitzpatrick J; Rai B; Cunningham J; Pratt N; Fleming S; Nabi G
Biomed Res Int; 2014; 2014():521380. PubMed ID: 24877109
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma.
Cairns P
Cancer Biomark; 2010; 9(1-6):461-73. PubMed ID: 22112490
[TBL] [Abstract][Full Text] [Related]
8. Signaling pathways in renal cell carcinoma.
Banumathy G; Cairns P
Cancer Biol Ther; 2010 Oct; 10(7):658-64. PubMed ID: 20814228
[TBL] [Abstract][Full Text] [Related]
9. Ovarian clear cell adenocarcinoma: a continuing enigma.
Tan DS; Kaye S
J Clin Pathol; 2007 Apr; 60(4):355-60. PubMed ID: 17018684
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity and methylation of p16 in renal cell carcinoma.
Sanz-Casla MT; Maestro ML; del Barco V; Zanna I; Moreno J; Vidaurreta M; Almansa I; Fernández C; Blanco J; Maestro C; Resel L
Urol Res; 2003 Jul; 31(3):159-62. PubMed ID: 12883879
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation.
Dent J; Hall GD; Wilkinson N; Perren TJ; Richmond I; Markham AF; Murphy H; Bell SM
Br J Cancer; 2003 May; 88(10):1578-83. PubMed ID: 12771925
[TBL] [Abstract][Full Text] [Related]
12. Aberrations of the p14(ARF) and p16(INK4a) genes in renal cell carcinomas.
Kawada Y; Nakamura M; Ishida E; Shimada K; Oosterwijk E; Uemura H; Hirao Y; Chul KS; Konishi N
Jpn J Cancer Res; 2001 Dec; 92(12):1293-9. PubMed ID: 11749694
[TBL] [Abstract][Full Text] [Related]
13. Recessive oncogenes: current status.
Gao X; Honn KV
Pathol Oncol Res; 1995; 1(1):7-22. PubMed ID: 11173562
[TBL] [Abstract][Full Text] [Related]
14. CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.
Schraml P; Struckmann K; Bednar R; Fu W; Gasser T; Wilber K; Kononen J; Sauter G; Mihatsch MJ; Moch H
Am J Pathol; 2001 Feb; 158(2):593-601. PubMed ID: 11159196
[TBL] [Abstract][Full Text] [Related]
15. Two target regions of allelic loss on chromosome 9 in urinary-bladder cancer.
Ohgaki K; Minobe K; Kurose K; Iida A; Habuchi T; Ogawa O; Kubota Y; Akimoto M; Emi M
Jpn J Cancer Res; 1999 Sep; 90(9):957-64. PubMed ID: 10551324
[TBL] [Abstract][Full Text] [Related]
16. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization.
Bissig H; Richter J; Desper R; Meier V; Schraml P; Schäffer AA; Sauter G; Mihatsch MJ; Moch H
Am J Pathol; 1999 Jul; 155(1):267-74. PubMed ID: 10393858
[TBL] [Abstract][Full Text] [Related]
18. Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer.
Minobe K; Onda M; Iida A; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Jpn J Cancer Res; 1998 Sep; 89(9):916-22. PubMed ID: 9818027
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.
Marsh KL; Varley JM
Br J Cancer; 1998 May; 77(9):1439-47. PubMed ID: 9652759
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
